PayloopPayloop
CommunityVoicesToolsDiscoverLeaderboardReportsBlog
Save Up to 65% on AI
Powered by Payloop — LLM Cost Intelligence
Tools/Recursion vs Viz.ai
Recursion

Recursion

ai-healthcare
vs
Viz.ai

Viz.ai

ai-healthcare

Recursion vs Viz.ai — Comparison

Overview
What each tool does and who it's for

Recursion

Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us

Recursion was founded more than a decade ago on the idea that we could take images of cells and use these images to train artificial intelligence to understand the vast unknown biological space – the cellular disruptions driving disease – to use AI-drug discovery to reduce the massive 90% failure rate of traditional drug discovery. Recursion Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas Leveraging the Power of Patient Data in AI-Drug Discovery Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market

Viz.ai

Viz.ai closes the gaps between patients, clinicians, and life-saving treatments with its leading-edge AI-powered care coordination solution.

Press Release: Viz.ai Launches Viz Agent Studio Enabling Health Systems to Build and Scale Their Own AI Care Pathways Viz.ai uses artificial intelligence to accelerate care coordination, reducing systemic delays that stand between patients and life-saving treatments. It’s an innovative way of using technology to transform clinical workflow and patient care. Viz.ai was inspired by a patient who underwent a successful brain surgery and yet died because the surgery came too late. Systemic – but preventable – process delays had undermined the work of her care team. Frustrated by the unnecessary delays that had cost his patient her life, neurosurgeon Dr. Chris Mansi committed to finding a better way. Dr. Mansi joined forces with machine learning post-doc Dr. David Golan and together they founded Viz.ai, in 2016, with a goal of using artificial intelligence to make healthcare work faster and smarter. Not just to change it – but to radically transform it. We’re here for our patients, they impact every decision. We move quickly, because every patient deserves access to life saving treatment. We play by the rules and deliver excellence. We strive to build a culture of kindness. I do what I say I will do, I follow through and follow up. We’re always looking for talented individuals to join our team and our mission. Meet our executive team made up of industry experts, who cultivate our culture and lead the people who are driving the AI healthcare revolution. See for yourself how you can harness the power of AI to accelerate patient access to care through AI-powered care coordination.

Key Metrics
—
Avg Rating
—
0
Mentions (30d)
0
—
GitHub Stars
—
—
GitHub Forks
—
—
npm Downloads/wk
—
—
PyPI Downloads/mo
—
Community Sentiment
How developers feel about each tool based on mentions and reviews

Recursion

0% positive100% neutral0% negative

Viz.ai

0% positive100% neutral0% negative
Pricing

Recursion

tiered

Viz.ai

tiered
Use Cases
When to use each tool

Recursion (1)

The future of TechBio
Features

Only in Recursion (10)

The future of TechBioLEARN HOWDecoding biology to radically improve livesBetter medicines, through novel insights and precision designDelivering for our partners3 key ingredients: data, models, and computeThe latest from RecursionGet In TouchGet InvolvedPolicies

Only in Viz.ai (2)

Agentic AI — Healthcare Isn’t Waiting. Pharma Can’t EitherExperience the power of AI
Product Screenshots

Recursion

Recursion screenshot 1

Viz.ai

Viz.ai screenshot 1Viz.ai screenshot 2Viz.ai screenshot 3
Company Intel
research
Industry
hospital & health care
800
Employees
330
—
Funding
$291.5M
—
Stage
Venture (Round not Specified)
Supported Languages & Categories

Recursion

AI/MLDeveloper Tools

Viz.ai

AI/ML
View Recursion Profile View Viz.ai Profile